|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||
REVIEWS AND ORIGINAL ARTICLES |
1 Division of Nephrology, Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio, and2 Dialysis Clinic, Inc., Cincinnati, Ohio
Correspondence to: K. Shashi Kant, Division of Nephrology, Mail Location 585, 231 Bethesda Avenue, Room 5363, Cincinnati, Ohio 45267-0585.
Relapsing peritonitis was assessed in the continuous ambulatory peritoneal
dialysis (CAPD) population of a large, outpatient dialysis facility. Prolonged
systemic treatment with antibiotics often fails, resulting in the eventual
removal and subsequent reimplantation of the catheter. We have tried a new
approach to avoid removal of the peritoneal catheter. Patients were treated by
the interruption of CAPD, conversion to hemodialysis or discontinuation of
dialysis for a period of 7 to 21 days while continuing systemic antibiotics.
Over a period of 76.63 patient years, 69 episodes of bacterial peritonitis
occurred (0.9 episodes per patient year). Of these, five episodes could be
classified as relapsing peritonitis. Five patients with gram-positive
relapsing peritonitis were treated by this regimen; all responded with a cure.
Our results suggest that relapsing peritonitis can be eradicated without the
removal of the peritoneal catheter.
KEY WORDS: Relapsing peritonitis; intraperitoneal (i.p.) antibiotic therapy; phagocytic activity; opsonins; macrophage function.
Received 3 January 1988; accepted 8 February 1988.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |